Allurion Technologies, Inc. (ALUR): Shareholders' Equity
-$77.19M
As of 2025-12-31
-$77.91M
As of 2026-03-31
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$77.19M | n/m | 2026-03-30, Balance as of period end |
| 2024-12-31 | -$77.98M | n/a | 2026-03-30, Balance as of period end |
| 2024-09-30 | -$64.79M | n/a | 2025-08-19, Balance as of period end |
| 2024-06-30 | -$70.58M | n/a | 2025-08-19, Balance as of period end |
| 2024-03-31 | -$66.16M | n/a | 2025-08-19, Balance as of period end |
| 2023-12-31 | -$71.30M | n/m | 2025-08-28, Balance as of period end |
| 2022-12-31 | -$32.31M | n/a | 2025-08-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$77.19M | n/m |
| Biotricity Inc. (BTCY) | 2026-03-31 | -$34.68M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | $66.43M | +10.0% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$1.49M | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $10.20M | +18.8% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $3.10M | -29.8% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$5.73M | n/m |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $4.46M | -22.5% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $67.92M | -5.7% |
Compare ALUR, BTCY, PROF, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗